Is There a Role for Opioids in the Treatment of Fibromyalgia?

References

• Sicras-Mainar A , RejasJ , NavarroRet al. Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study . Arthritis Res. Ther.11 ( 2 ), R54 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hoffman DL , DukesEM . The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12 . Int. J. Clin. Pract.62 ( 1 ), 115 – 126 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Nuesch E , HauserW , BernardyK , BarthJ , JuniP . Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis . Ann. Rheum. Dis.72 ( 6 ), 955 – 962 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Painter JT , CroffordLJ . Chronic opioid use in fibromyalgia syndrome: a clinical review . J. Clin. Rheumatol.19 ( 2 ), 72 – 77 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Marschall U , L’hoestH , RadbruchL , HauserW . Long-term opioid therapy for chronic non-cancer pain in Germany . Eur. J. Pain20 ( 5 ), 767 – 776 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Peng X , RobinsonRL , MeasePet al. Long-term evaluation of opioid treatment in fibromyalgia . Clin. J. Pain31 ( 1 ), 7 – 13 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Alford DP . Opioid prescribing for chronic pain – achieving the right balance through education . N. Engl. J. Med.374 ( 4 ), 301 – 303 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Wolfe F , AndersonJ , HarknessDet al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia . Arthritis Rheum.40 ( 9 ), 1560 – 1570 ( 1997 ).
   PubMedGoogle Scholar
• Berger A , SadoskyA , DukesEM , EdelsbergJ , ZlatevaG , OsterG . Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia . Am. J. Manag. Care16 ( 5 Suppl. ), S126 – S137 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ngian GS , GuymerEK , LittlejohnGO . The use of opioids in fibromyalgia . Int. J. Rheum. Dis.14 ( 1 ), 6 – 11 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wolfe F , SmytheHA , YunusMBet al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee . Arthritis Rheum.33 ( 2 ), 160 – 172 ( 1990 ).
   PubMed Web of Science ®Google Scholar
• Wolfe F , ClauwDJ , FitzcharlesMAet al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity . Arthritis Care Res. (Hoboken)62 ( 5 ), 600 – 610 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Clauw DJ . Fibromyalgia: a clinical review . JAMA311 ( 15 ), 1547 – 1555 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Granges G , LittlejohnG . Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome . Arthritis Rheum.36 ( 5 ), 642 – 646 ( 1993 ).
   PubMedGoogle Scholar
• Fitzcharles MA , ShirY , AblinJNet al. Classification and clinical diagnosis of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines . Evid. Based Complement. Alternat. Med.2013 , 528952 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gracely RH , SchweinhardtP . Programmed symptoms: disparate effects united by purpose . Curr. Rheumatol. Rev.11 ( 2 ), 116 – 130 ( 2015 ).
   PubMedGoogle Scholar
• Fischer S , DoerrJM , StrahlerJ , MewesR , ThiemeK , NaterUM . Stress exacerbates pain in the everyday lives of women with fibromyalgia syndrome – the role of cortisol and alpha-amylase . Psychoneuroendocrinology63 , 68 – 77 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Malin K , LittlejohnGO . Stress modulates key psychological processes and characteristic symptoms in females with fibromyalgia . Clin. Exp. Rheumatol.31 ( 6 Suppl. 79 ), S64 – S71 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gibson SJ , LittlejohnGO , GormanMM , HelmeRD , GrangesG . Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome . Pain58 ( 2 ), 185 – 193 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Littlejohn GO . Balanced treatments for fibromyalgia . Arthritis Rheum.50 ( 9 ), 2725 – 2729 ( 2004 ).
   PubMedGoogle Scholar
• Usui C , HattaK , DoiNet al. Brain perfusion in fibromyalgia patients and its differences between responders and poor responders to gabapentin . Arthritis Res. Ther.12 ( 2 ), R64 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Napadow V , KimJ , ClauwDJ , HarrisRE . Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia . Arthritis Rheum.64 ( 7 ), 2398 – 2403 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Pujol J , MaciaD , Garcia-FontanalsAet al. The contribution of sensory system functional connectivity reduction to clinical pain in fibromyalgia . Pain155 ( 8 ), 1492 – 1503 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Clauw DJ , ArnoldLM , MccarbergBH , Fibrocollaborative . The science of fibromyalgia . Mayo Clin. Proc.86 ( 9 ), 907 – 911 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hauser W , AblinJ , FitzcharlesMA , LittlejohnG , LucianoJV , WalittB . Fibromyalgia . Nat. Rev. Dis. Prim.1 , 1 – 16 ( 2015 ).
   Web of Science ®Google Scholar
• Littlejohn G . Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome . Nat. Rev. Rheumatol.11 ( 11 ), 639 – 648 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kemple Kl , SmithG , JW-N . Opioid therapy in fibromyalgia: a four year prospective evaluation of therapy selection, efficacy, and predictions of outcome . Arthritis Rheum.48 , S88 ( 2003 ).
   Google Scholar
• Guymer E , LittlejohnG . Fibromylagia . Aust. Fam. Physician42 ( 10 ), 690 – 694 ( 2013 ).
   PubMedGoogle Scholar
• Yunus MB , DenkoCW , MasiAT . Serum beta-endorphin in primary fibromyalgia syndrome: a controlled study . J. Rheumatol.13 ( 1 ), 183 – 186 ( 1986 ).
   PubMed Web of Science ®Google Scholar
• Hall S , LittlejohnGO , GethwaJ , CopolovD . Plasm beta-endorphinlevels in fibrositis . Arthritis Rheum.23 , 539 ( 1983 ).
   Google Scholar
• Baraniuk JN , WhalenG , CunninghamJ , ClauwDJ . Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain . BMC Musculoskelet. Disord.5 , 48 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Harris RE , ClauwDJ , ScottDJ , McleanSA , GracelyRH , ZubietaJK . Decreased central mu-opioid receptor availability in fibromyalgia . J. Neurosci.27 ( 37 ), 10000 – 10006 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Buckhardt CS , GoldenbergD , CroffordLet al. Guideline for the Management of Fibromyalgia Syndrome Pain in Adults and Children ( 2005 ). http://teamworkstherapy.com/pdf/APS%20guideline-%20Fibromyalgia.pdf .
   Google Scholar
• Carville SF , Arendt-NielsenS , BliddalHet al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome . Ann. Rheum. Dis.67 ( 4 ), 536 – 541 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Boomershine CS , CroffordLJ . A symptom-based approach to pharmacologic management of fibromyalgia . Nat. Rev. Rheumatol.5 ( 4 ), 191 – 199 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hauser W , EichW , HerrmannM , NutzingerDO , SchiltenwolfM , HenningsenP . Fibromyalgia syndrome: classification, diagnosis, and treatment . Dtsch. Arztebl. Int.106 ( 23 ), 383 – 391 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Goldenberg D . Treatment of fibromyalgia in adults not responsive to initial therapies . UptoDate ( 2016 ). www.uptodate.com/contents/treatment-of-fibromyalgia-in-adults-not-responsive-to-initial-therapies .
   Google Scholar
• Gaskell H , MooreRA , DerryS , StannardC . Oxycodone for neuropathic pain and fibromyalgia in adults . Cochrane Database Syst. Rev.6 , CD010692 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Furlan AD , SandovalJA , Mailis-GagnonA , TunksE . Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects . CMAJ174 ( 11 ), 1589 – 1594 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Rafiq SM , RashidH , HaworthE , BooyR . Hazards of hepatitis at the Hajj . Travel Med. Infect. Dis.7 ( 4 ), 239 – 246 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Fitzcharles MA , Ste-MariePA , GamsaA , WareMA , ShirY . Opioid use, misuse, and abuse in patients labeled as fibromyalgia . Am. J. Med.124 ( 10 ), 955 – 960 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Cunningham JL , EvansMM , KingSM , GehinJM , LoukianovaLL . Opioid tapering in fibromyalgia patients: experience from an interdisciplinary pain rehabilitation program . Pain Med. doi:10.1093/pm/pnv079 ( 2016 ) ( Epub ahead of print ).
   Web of Science ®Google Scholar
• Wolfe F , WalittBT , KatzRS , LeeYC , MichaudKD , HauserW . Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia . Eur. J. Pain17 ( 4 ), 581 – 586 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Sorensen J , BengtssonA , BackmanE , HenrikssonKG , BengtssonM . Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine . Scand. J. Rheumatol.24 ( 6 ), 360 – 365 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Biasi G , MancaS , ManganelliS , MarcolongoR . Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo . Int. J. Clin. Pharmacol. Res.18 ( 1 ), 13 – 19 ( 1998 ).
   PubMedGoogle Scholar
• Bennett RM , KaminM , KarimR , RosenthalN . Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study . Am. J. Med.114 ( 7 ), 537 – 545 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Bennett RM , ScheinJ , KosinskiMR , HewittDJ , JordanDM , RosenthalNR . Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen . Arthritis Rheum.53 ( 4 ), 519 – 527 ( 2005 ).
   PubMedGoogle Scholar
• Russell IJ , KaminM , BennettRM , SchnitzerTJ , GreenJA , KatzWA . Efficacy of tramadol in treatment of pain in fibromyalgia . J. Clin. Rheumatol.6 ( 5 ), 250 – 257 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Maclean AJ , SchwartzTL . Tramadol for the treatment of fibromyalgia . Expert Rev. Neurother.15 ( 5 ), 469 – 475 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Tzschentke TM , ChristophT , KogelBY . The mu-opioid receptor agonist/noradrenaline reuptake inhibition (MOR-NRI) concept in analgesia: the case of tapentadol . CNS Drugs28 ( 4 ), 319 – 329 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Baron R , JansenJP , BinderAet al. Tolerability, safety, and quality of life with tapentadol prolonged release (PR) compared with oxycodone/naloxone PR in patients with severe chronic low back pain with a neuropathic component: a randomized, controlled, open-label, Phase 3b/4 trial . Pain Pract. doi:10.1111/papr.12361 ( 2015 ) ( Epub ahead of print ).
   Web of Science ®Google Scholar
• Raffa RB , BuschmannH , ChristophTet al. Mechanistic and functional differentiation of tapentadol and tramadol . Expert Opin. Pharmacother.13 ( 10 ), 1437 – 1449 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Burness CB , KeatingGM . Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation . Drugs74 ( 3 ), 353 – 375 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lowenstein O , LeyendeckerP , LuxEAet al. Efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials . BMC Clin. Pharmacol.10 , 12 ( 2010 ).
   PubMedGoogle Scholar
• Xanthos DN , SandkuhlerJ . Neurogenic neuroinflammation: inflammatory reactions in response to neuronal activity . Nat. Rev. Neurosci.15 , 43 – 53 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Younger J , ParkitnyL , MclainD . The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain . Clin. Rheumatol.33 ( 4 ), 451 – 459 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Younger J , MackeyS . Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study . Pain Med.10 ( 4 ), 663 – 672 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Younger J , NoorN , MccueR , MackeyS . Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels . Arthritis Rheum.65 ( 2 ), 529 – 538 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yunus MB . Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness . Semin. Arthritis Rheum.37 ( 6 ), 339 – 352 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kotter I , DurkH , SaalJG , KroiherA , SchweinsbergF . Mercury exposure from dental amalgam fillings in the etiology of primary fibromyalgia: a pilot study . J. Rheumatol.22 ( 11 ), 2194 – 2195 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Chu LF , AngstMS , ClarkD . Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations . Clin. J. Pain24 ( 6 ), 479 – 496 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Watkins LR , HutchinsonMR , RiceKC , MaierSF . The “toll” of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia . Trends Pharmacol. Sci.30 ( 11 ), 581 – 591 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Koppert W , IhmsenH , KorberNet al. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model . Pain118 ( 1–2 ), 15 – 22 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Littlejohn GO , GuymerEK . In clinical practice, the term “central sensitivity score” is more useful than the term “polysymptomatic distress scale”: comment on the editorial by Wolfe . Arthritis Rheum.67 ( 9 ), 2553 ( 2015 ).
   Web of Science ®Google Scholar